TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8736053

Group type: EXPERIMENTAL
Intervention: Rhinomer (cleansing preparation of isotonic, sterile, undiluted sea water)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Prorhinel (marketed solution containing an antiseptic agent)
Number of subjects: 28
Study: 1928767

Group type: EXPERIMENTAL
Intervention: Clonidine (5 micrograms/kg infused the 1st hour and then 0.3 microgram-1.kg-1.h-1 during 11 hours)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7121093

Group type: EXPERIMENTAL
Intervention: Specialized telephone service
Number of subjects: 561

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 561
Study: 30095158

Group type: EXPERIMENTAL
Intervention: MCL35 gene expression proliferation assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ki‐67 index
Number of subjects: 0

Group type: COMPARATOR
Intervention: MIPI
Number of subjects: 0
Study: 28424068

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Internet‐based protocol (TIBP)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Internet‐based protocol + positive affect component (TIBP + PA)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Waiting List control group (WL)
Number of subjects: 207
Study: 26026580

Group type: EXPERIMENTAL
Intervention: Ramelteon (8 mg nightly for 3 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 24411681

Group type: EXPERIMENTAL
Intervention: Music therapy during labor
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 161
Study: 21103989

Group type: EXPERIMENTAL
Intervention: 35-g/m2 titanized polypropylene mesh (Group A)
Number of subjects: 380

Group type: COMPARATOR
Intervention: 16-g/m2 titanized polypropylene mesh (Group B)
Number of subjects: 380
Study: 19116896

Group type: EXPERIMENTAL
Intervention: Sodium oxybate 4.5 gm
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sodium oxybate 6 gm
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (both dosages)
Number of subjects: 188
Study: 18612886

Group type: EXPERIMENTAL
Intervention: Illicit methadone use in the past month
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: History of regular illicit methadone use
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Younger age and history of outpatient psychological treatment
Number of subjects: 383
Study: 15820760

Group type: EXPERIMENTAL
Intervention: O-[11C]methyl-L-tyrosine
Number of subjects: 0
Study: 12076342

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (EX) for 30‐60 min three to five times a week at 40‐60% of maximal oxygen consumption
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (EX)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 112
Study: 10208495

Group type: EXPERIMENTAL
Intervention: Vitamin E 1000 IU/day
Number of subjects: 20
Study: 7797807

Group type: EXPERIMENTAL
Intervention: High vegetable/fruit diet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Legume/allium diet (containing garbanzo beans, garlic, and onions)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Basal diet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Legume/allium diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Controlled basal diet
Number of subjects: 10
Study: 2128094

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (170 micrograms/min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Phentolamine (1-1.5 mg/min)
Number of subjects: 22
Study: 368087

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 341

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 341
Study: 30808625

Group type: EXPERIMENTAL
Intervention: golimumab (50 mg SC monthly) + MTX (n=26)
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo + MTX (n=25)
Number of subjects: 51
Study: 28411697

Group type: EXPERIMENTAL
Intervention: Endovenous cyanoacrylate closure (CAC)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 222
Study: 25424398

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) - 16 weekly sessions
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 31
Study: 23587190

Group type: EXPERIMENTAL
Intervention: 35,000 IU/week of vitamin D3
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 21340544

Group type: EXPERIMENTAL
Intervention: Titanium elastic nailing (TEN)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hip spica cast
Number of subjects: 46
Study: 18440534

Group type: EXPERIMENTAL
Intervention: Metformin (1700 mg/day for 6 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) (50 mg/day, increasing doses up to 250 mg/day)
Number of subjects: 80
Study: 17366011

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam 18/9 g daily dose (group A)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam 24/12 g daily dose (group B)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam (both groups)
Number of subjects: 27
Study: 14715352

Group type: COMPARATOR
Intervention: HRT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HRT + simvastatin
Number of subjects: 16
Study: 11386264

Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 2708

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2708
Study: 9140570

Group type: EXPERIMENTAL
Intervention: 29-item self-report inventory for screening major mental disorders
Number of subjects: 483

Group type: COMPARATOR
Intervention: 46-item inventory (initial version)
Number of subjects: 483
Study: 8173851

Group type: EXPERIMENTAL
Intervention: Hydrocortisone succinate (HC)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetonide (TH)
Number of subjects: 300
Study: 2906477

Group type: EXPERIMENTAL
Intervention: Olsalazine, 500 mg b.d.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sulphasalazine, 1 g b.d.
Number of subjects: 82
Study: 29685343

Group type: EXPERIMENTAL
Intervention: Cabazitaxel Q1W, 10 mg/m2
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cabazitaxel Q3W, 25 mg/m2
Number of subjects: 101
Study: 28093636

Group type: EXPERIMENTAL
Intervention: Shock wave therapy
Number of subjects: 143

Group type: COMPARATOR
Intervention: No shock wave therapy (control group)
Number of subjects: 143
Study: 26268930

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (aerobic training for 35 minutes at 60-80% intensity, strength training for quadriceps, biceps, and deltoids at 40-70% intensity, and use of Flutter® device for 5 minutes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest physiotherapy + stretching exercises (control group)
Number of subjects: 0
Study: 23640324

Group type: EXPERIMENTAL
Intervention: Lumbar extension traction in addition to stretching exercises and infrared radiation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Stretching exercises and infrared radiation (Control)
Number of subjects: 80
Study: 21356013

Group type: EXPERIMENTAL
Intervention: Microbead dentifrice
Number of subjects: 22
Study: 18711387

Group type: EXPERIMENTAL
Intervention: 16-session behavioral weight loss program (first-time participants)
Number of subjects: 2808

Group type: COMPARATOR
Intervention: 16-session behavioral weight loss program (repeat participants)
Number of subjects: 2808
Study: 16770092

Group type: EXPERIMENTAL
Intervention: Trastuzumab (Herceptin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab with paclitaxel
Number of subjects: 0
Study: 14597939

Group type: EXPERIMENTAL
Intervention: Thin-strut stent (n = 326)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Thick-strut stent (n = 325)
Number of subjects: 651
Study: 10983676

Group type: EXPERIMENTAL
Intervention: Allopurinol (1 g)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 8703453

Group type: EXPERIMENTAL
Intervention: Continuous cuff pressure monitoring (Group 2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard cuff pressure monitoring (Group 1)
Number of subjects: 200
Study: 1558834

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/day for 10 days)
Number of subjects: 6
Study: 3911365

Group type: EXPERIMENTAL
Intervention: Antacid group (4 chewable aluminum-magnesium-antacid tablets daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Antacid group
Number of subjects: 80
Study: 31944472

Group type: EXPERIMENTAL
Intervention: 18-month weight management intervention (reduced calorie diet, 150 min of moderate-vigorous intensity physical activity per week, daily dietary logging, monthly at-home visits by a health educator)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 18-month weight management intervention
Number of subjects: 124
Study: 28981834

Group type: EXPERIMENTAL
Intervention: Sleep loss condition (restricted to 4 h sleep for 3 nights)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control condition (standard sleep)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Sleep loss condition
Number of subjects: 68
Study: 27906919

Group type: EXPERIMENTAL
Intervention: Scratch test
Number of subjects: 50

Group type: COMPARATOR
Intervention: Percussion test
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Scratch test (young trainees)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Percussion test (young trainees)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Percussion test (first 25 subjects)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Scratch test (first 25 subjects)
Number of subjects: 50
Study: 24569001

Group type: EXPERIMENTAL
Intervention: Employer-provided insurance
Number of subjects: 5755

Group type: EXPERIMENTAL
Intervention: Spousal insurance
Number of subjects: 5755

Group type: EXPERIMENTAL
Intervention: Market insurance
Number of subjects: 5755

Group type: COMPARATOR
Intervention: Baseline models (no specific intervention)
Number of subjects: 5755
Study: 23258136

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride (10 µg/kg/min, continuous intravenous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no landiolol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride
Number of subjects: 60
Study: 21085712

Group type: EXPERIMENTAL
Intervention: Indirect comparisons using randomised controlled trials
Number of subjects: 43
Study: 18501909

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg intravenous dose
Number of subjects: 43
Study: 15987918

Group type: EXPERIMENTAL
Intervention: Oral capecitabine (1004 patients)
Number of subjects: 1987

Group type: COMPARATOR
Intervention: Bolus fluorouracil plus leucovorin (983 patients)
Number of subjects: 1987
Study: 14525817

Group type: EXPERIMENTAL
Intervention: Ropivacaine 60 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Midazolam 0.03 mg/kg prior to ropivacaine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11027451

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 11
Study: 8808721

Group type: EXPERIMENTAL
Intervention: Ifosfamide 5 g/m2xdx1 and doxorubicin 60 mg/m2xdx1 given every 3 weeks with r‐met Hu G‐CSF (250 micrograms/m2xd)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ifosfamide 1.8 g/m2xdx5 and doxorubicin 60 mg/m2xdx1 given every 4 weeks
Number of subjects: 60
Study: 1419009

Group type: EXPERIMENTAL
Intervention: IM ketorolac 30 mg while in the PACU, followed by 15 mg every 6 hours
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: IM ketorolac 60 mg while in the PACU, followed by 30 mg every 6 hours
Number of subjects: 35

Group type: COMPARATOR
Intervention: IV PCA morphine
Number of subjects: 35

Group type: COMPARATOR
Intervention: IM saline every 6 hours
Number of subjects: 35
Study: 6198912

Group type: EXPERIMENTAL
Intervention: Normal male expectancy condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Normal female expectancy condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Developmentally delayed male expectancy condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Developmentally delayed female expectancy condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Label 'developmentally delayed'
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Verbal prompts
Number of subjects: 40
Study: 30721941

Group type: EXPERIMENTAL
Intervention: Lipid-based micronutrient supplement commenced ≥3 months before conception (Arm 1)
Number of subjects: 7387

Group type: EXPERIMENTAL
Intervention: Lipid-based micronutrient supplement commenced late in the first trimester of pregnancy (Arm 2)
Number of subjects: 7387

Group type: COMPARATOR
Intervention: Control group (Arm 3)
Number of subjects: 7387
Study: 28668540

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 27113302

Group type: EXPERIMENTAL
Intervention: Solution-focused approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing and psychological guidance
Number of subjects: 120
Study: 25136038

Group type: EXPERIMENTAL
Intervention: VIS and information emphasizing the MMR vaccine's benefits to the child
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: VIS and information emphasizing benefits both to the child and society
Number of subjects: 802

Group type: COMPARATOR
Intervention: VIS only
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: VIS and information emphasizing societal benefits
Number of subjects: 802
Study: 22190555

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.30 mg/kg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.05 to 0.20 mg/kg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Midazolam (0.075 mg/kg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Remimazolam (0.10 and 0.15 mg/kg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Remimazolam and Midazolam
Number of subjects: 81
Study: 20107469

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 202
Study: 17287638

Group type: EXPERIMENTAL
Intervention: Batroxobin
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (no batroxobin)
Number of subjects: 112
Study: 11160991

Group type: EXPERIMENTAL
Intervention: Government intervention strategies implemented in the tuna farming industry.
Number of subjects: 17
Study: 9311393

Group type: COMPARATOR
Intervention: Thiopental 5 mg kg‐1 induction and isoflurane maintenance (Group T/I)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg kg‐1 induction, 5 mg kg‐1 h‐1 maintenance (Group P5)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg kg‐1 induction, 10 mg kg‐1 h‐1 maintenance (Group P10)
Number of subjects: 90
Study: 8354977

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 28
Study: 3088859

Group type: EXPERIMENTAL
Intervention: Enprostil 35 micrograms b.i.d.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Ranitidine 150 mg b.i.d.
Number of subjects: 93
Study: 30468145

Group type: EXPERIMENTAL
Intervention: Mirtazapine (15 mg daily for 2 weeks, then 30 mg daily for up to 12 months)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 480
Study: 27340354

Group type: EXPERIMENTAL
Intervention: Adjuvant sorafenib
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (curative hepatectomy without sorafenib)
Number of subjects: 34
Study: 25172798

Group type: EXPERIMENTAL
Intervention: Korodin(®) (20 drops administered four times with 10 min intervals)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (20 drops administered four times with 10 min intervals)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Korodin(®)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 22415678

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 μg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 60
Study: 19944431

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 21
Study: 18450618

Group type: EXPERIMENTAL
Intervention: Highly cross-linked polyethylene
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard polyethylene
Number of subjects: 54
Study: 15812079

Group type: EXPERIMENTAL
Intervention: Menopausal hormone therapy
Number of subjects: 378

Group type: COMPARATOR
Intervention: No menopausal hormone therapy
Number of subjects: 378
Study: 14516801

Group type: EXPERIMENTAL
Intervention: Patching treatment (6 hours per day up to all waking hours)
Number of subjects: 209
Study: 10795832

Group type: EXPERIMENTAL
Intervention: Ioxaglate
Number of subjects: 189

Group type: COMPARATOR
Intervention: Iobitridol
Number of subjects: 189
Study: 9679606

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 0

Group type: COMPARATOR
Intervention: H2-receptor antagonists and proton pump inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drugs for erosions
Number of subjects: 0
Study: 1500398

Group type: EXPERIMENTAL
Intervention: Flosequinan 50 mg daily for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30383333

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 482

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Lithium or Quetiapine
Number of subjects: 482
Study: 28395435

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural anesthesia and epidural analgesia (GE)
Number of subjects: 96

Group type: COMPARATOR
Intervention: General anesthesia and intravenous analgesia (GI)
Number of subjects: 96
Study: 26547293

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remifentanil plus flurbiprofen axetil
Number of subjects: 60
Study: 23003913

Group type: EXPERIMENTAL
Intervention: Immediately Loaded (IL) DLMF transitional implants
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unloaded (UI) DLMF transitional implants
Number of subjects: 12
Study: 22225438

Group type: EXPERIMENTAL
Intervention: Written feedback from standardized patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of written and verbal feedback from standardized patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention groups (written and verbal feedback)
Number of subjects: 0
Study: 19923803

Group type: EXPERIMENTAL
Intervention: Chitosan
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 18555088

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate-sodium (EC-MPS) 720 mg b.i.d
Number of subjects: 154

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 1000 mg b.i.d
Number of subjects: 154
Study: 16018522

Group type: EXPERIMENTAL
Intervention: Topical dimethylsulfoxide (DMSO)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Topical saline (Control)
Number of subjects: 66
Study: 12185791

Group type: EXPERIMENTAL
Intervention: Prospective reports of exposure during pregnancy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Retrospective reports of exposure 3-7 years after pregnancy
Number of subjects: 29
Study: 10522577

Group type: EXPERIMENTAL
Intervention: Thigh tourniquet inflated during surgery (Group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No thigh tourniquet inflated during surgery (Group II)
Number of subjects: 30
Study: 7856780

Group type: EXPERIMENTAL
Intervention: Early intervention (18-month multifaceted program with employee steering committee and tailored activities)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Delayed intervention (control group)
Number of subjects: 26
Study: 1835851

Group type: EXPERIMENTAL
Intervention: iproplatin
Number of subjects: 47

Group type: COMPARATOR
Intervention: carboplatin
Number of subjects: 47
Study: 6120980

Group type: EXPERIMENTAL
Intervention: 100 or 112 microgram of a pili vaccine prepared from Neisseria gonorrhoeae strain F62 in Tris buffer with an aluminum phosphate adjuvant (alum)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 220 microgram of the F62 pili vaccine prepared in ethanolamine, with or without alum
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Postimmunization sera
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Preabsorption of the sera with strain F62 pili
Number of subjects: 39
Study: 30957833

Group type: EXPERIMENTAL
Intervention: MIX (1:1 blend of sodium selenite and SEL-PLEX)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OSe (SEL-PLEX)
Number of subjects: 24

Group type: COMPARATOR
Intervention: ISe (sodium selenite)
Number of subjects: 24
Study: 28745912

Group type: EXPERIMENTAL
Intervention: Psychological grief counseling (4 sessions over 2 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine postnatal care (control group)
Number of subjects: 100
Study: 25913893

Group type: EXPERIMENTAL
Intervention: Fluoride rinse (sodium fluoride and amine fluoride), used every evening after toothbrushing
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo rinse, used every evening after toothbrushing
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Fluoride rinse
Number of subjects: 81
Study: 23876588

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 22428487

Group type: COMPARATOR
Intervention: Ropivacaine 1.5 mg ml(-1) plus fentanyl 2 microg ml(-1) (group F)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1.5 mg ml(-1) plus clonidine 1 microg ml(-1) (group C)
Number of subjects: 52
Study: 18533158

Group type: EXPERIMENTAL
Intervention: Simvastatin 80mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Simvastatin/ezetimibe 10mg/10mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Fat loading without treatment
Number of subjects: 19